Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
70.81
+1.18 (1.69%)
Nov 22, 2024, 4:00 PM EST - Market closed

Company Description

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.

It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.

The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents.

The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms.

The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes.

The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Solventum Corporation
Solventum logo
Country United States
Founded 2023
Industry Health Information Services
Sector Healthcare
Employees 20,098
CEO Bryan Hanson

Contact Details

Address:
3M Center, Building 275-6W
Saint Paul, Minnesota 55144
United States
Phone 651-733-1110
Website solventum.com

Stock Details

Ticker Symbol SOLV
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001964738
CUSIP Number 83444M101
ISIN Number US83444M1018
Employer ID 92-2008841
SIC Code 3841

Key Executives

Name Position
Bryan C. Hanson Chief Executive Officer and Director
Wayde D. McMillan Chief Financial Officer
Mary T. Wilcox Senior Vice President, Controller and Chief Accounting Officer
Amy Landucci Chief Information and Digital Officer
Marcela A. Kirberger Chief Legal Affairs Officer and Corporate Secretary
Sanjiv Arora Chief Strategy and Corporate Development Officer
Tammy L. Gomez Chief Human Resources Officer
Paul S. Harrington Chief Supply Chain Officer
Karim Mansour President of Dental Solutions
Garri Garrison President of Health Information Systems

Latest SEC Filings

Date Type Title
Nov 15, 2024 S-4 Filing
Nov 14, 2024 SCHEDULE 13G Filing
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 8, 2024 IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012
Nov 8, 2024 10-Q Quarterly Report
Nov 8, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 7, 2024 8-K Current Report
Nov 5, 2024 8-K Current Report
Nov 4, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 24, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals